Cardiologist-Friendly VAD Is In Demand; Manufacturers Advised To Start Small
This article was originally published in The Gray Sheet
Executive Summary
The ventricular assist device market will expand only if manufacturers appeal to general cardiologists with simpler, less invasive systems, surgeons said at the TCT 2004 conference in Washington, D.C
You may also be interested in...
Heart Failure Devices Must Be “Smarter,” Reverse Disease – HFSA President
Heart failure devices should reverse the underlying biochemical causes of disease instead of merely supporting or replacing a dysfunctional part, according to Heart Failure Society of America President Marvin Konstam, MD, New England Heart Center
Heart Failure Devices Must Be “Smarter,” Reverse Disease – HFSA President
Heart failure devices should reverse the underlying biochemical causes of disease instead of merely supporting or replacing a dysfunctional part, according to Heart Failure Society of America President Marvin Konstam, MD, New England Heart Center
Acorn Will Present CorCap Clinical Trial Update At ACC Meeting
Acorn Cardiovascular expects to complete enrollment for a 300-patient, randomized trial of its CorCap cardiac support device for heart failure by July